Article
Xanthone Derivatives as Potential Anti-cancer Drugs
1 May 1996
Abstract excerpt
Xanthone derivatives have been shown to be potent inhibitors of tumour growth. Oxygenated xanthones and [3-(dialkylamino)-2-hydroxypropoxy]xanthones have been prepared and tested for in-vitro inhibition of human PLC/PRF/5, KB and 212 cells. Structure-activity analysis indicated epoxidation of the hydroxyxanthone increased cytotoxicity against tumour cells but ring-opening of the epoxide group with dialkylamine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
